首页> 美国卫生研究院文献>Oncology Letters >Expression of PPARγ and PTEN in human colorectal cancer: An immunohistochemical study using tissue microarray methodology
【2h】

Expression of PPARγ and PTEN in human colorectal cancer: An immunohistochemical study using tissue microarray methodology

机译:PPARγ和PTEN在人大肠癌中的表达:使用组织芯片技术的免疫组织化学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although aberrations of peroxisome proliferator-activated receptor γ (PPARγ) and phosphatase and tensin homolog (PTEN) expression have been identified in several other cancer types, certain previous studies have revealed that PPARγ is abundant in normal and malignant tissue in the colon. The question of whether aberrant PTEN is involved in the initial stage or is a later event during colorectal carcinogenesis remains controversial. Relatively few studies have focused on the correlation of expression of PPARγ and PTEN in various tissues. In the present study, paraffin-embedded blocks from 139 patients with CRC, 18 adenomatous polyps and 50 paired paracancerous benign mucosas were selected and analysed in 4 tissue microarray (TMA) blocks comprising 104, 72, 130 and 54 cores, respectively. Expression of PPARγ and PTEN was examined using immunohistochemical staining on TMAs. There were no significant differences in the expression of PPARγ (P=0.055) and PTEN (P=0.100) between the colorectal cancers, adenomas and paracancerous mucosas. However, correlations of PPARγ expression with clinical stage (P=0.004) and PTEN expression with histological grade (P=0.006) and distant metastasis (P=0.015) were demonstrated in the CRC specimens. Although the differences in PPARγ and PTEN protein expression in human colorectal cancer may not be considered as early diagnostic markers, our results indicate that CRCs with a low expression or deletion of PTEN may progress towards invasion and even metastasis; thus, PTEN may have potential as a prognostic marker in human CRC.
机译:尽管过氧化物酶体增殖物激活受体γ(PPARγ),磷酸酶和张力蛋白同源物(PTEN)表达的异常已在其他几种癌症类型中发现,但某些先前的研究表明,PPARγ在结肠的正常和恶性组织中含量丰富。 PTEN异常是在大肠癌发生的初始阶段还是以后的事件仍然存在争议。相对较少的研究集中在各种组织中PPARγ和PTEN表达的相关性。在本研究中,从139例CRC,18例腺瘤性息肉和50对配对的癌旁良性粘膜黏膜石蜡包埋块中选择并分析了4种组织微阵列(TMA)块,分别包含104、72、130和54个核心。在TMA上使用免疫组织化学染色检查PPARγ和PTEN的表达。大肠癌,腺瘤和癌旁黏膜之间PPARγ(P = 0.055)和PTEN(P = 0.100)的表达没有显着差异。然而,在CRC标本中证实了PPARγ表达与临床分期(P = 0.004)和PTEN表达与组织学分级(P = 0.006)和远处转移(P = 0.015)的相关性。尽管人大肠癌中PPARγ和PTEN蛋白表达的差异可能不被视为早期诊断标记,但我们的结果表明,PTEN表达或缺失水平低的CRC可能会进展为浸润甚至转移。因此,PTEN可能具有作为人类CRC预后标志物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号